Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Stephens

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methodsAleksandar Jovalekic, Núria Roé-Vellvé, Norman Koglin, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
GMP-Compliant Radiosynthesis of [<sup>18</sup>F]GP1, a Novel PET Tracer for the Detection of ThrombiVerena Hugenberg, Marion Zerna, Mathias Berndt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2019
Tau PET imaging with <sup>18</sup>F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans StudyAndre Mueller, Santiago Bullich, Olivier Barret, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 28, 2014
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome studyKevin T Ong, Victor L Villemagne, Alex Bahar-Fuchs, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2025
Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI studyGuilherme Domingues Kolinger, Oscar Sotolongo-Grau, Núria Roé-Vellvé, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2022
Quantification of amyloid PET for future clinical use: a state-of-the-art reviewHugh G Pemberton, Lyduine E Collij, Fiona Heeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate PET of Inflammatory and Infectious LesionsSun Young Chae, Chang-Min Choi, Tae Sun Shim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2026
First human whole-body biodistribution and dosimetry analysis of [<sup>18</sup>F]LW223, a novel TSPO PET radiotracerPhyo H Khaing, Mark G MacAskill, Jianfei Xiao, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization InsightsAleksandar Jovalekic, Santiago Bullich, Núria Roé-Vellvé, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2024
Centiloid recommendations for clinical context-of-use from the AMYPAD consortiumLyduine E Collij, Ariane Bollack, Renaud La Joie, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methodsAleksandar Jovalekic, Núria Roé-Vellvé, Norman Koglin, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
GMP-Compliant Radiosynthesis of [<sup>18</sup>F]GP1, a Novel PET Tracer for the Detection of ThrombiVerena Hugenberg, Marion Zerna, Mathias Berndt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2019
Tau PET imaging with <sup>18</sup>F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans StudyAndre Mueller, Santiago Bullich, Olivier Barret, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 28, 2014
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome studyKevin T Ong, Victor L Villemagne, Alex Bahar-Fuchs, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2025
Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI studyGuilherme Domingues Kolinger, Oscar Sotolongo-Grau, Núria Roé-Vellvé, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2022
Quantification of amyloid PET for future clinical use: a state-of-the-art reviewHugh G Pemberton, Lyduine E Collij, Fiona Heeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate PET of Inflammatory and Infectious LesionsSun Young Chae, Chang-Min Choi, Tae Sun Shim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2026
First human whole-body biodistribution and dosimetry analysis of [<sup>18</sup>F]LW223, a novel TSPO PET radiotracerPhyo H Khaing, Mark G MacAskill, Jianfei Xiao, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization InsightsAleksandar Jovalekic, Santiago Bullich, Núria Roé-Vellvé, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2024
Centiloid recommendations for clinical context-of-use from the AMYPAD consortiumLyduine E Collij, Ariane Bollack, Renaud La Joie, et al.
Pageof 8